AC Immune SA has a consensus price target of $11.33 based on the ratings of 10 analysis. The 3 most-recent analyst ratings were released by BTIG, HC Wainwright & Co., and HC Wainwright & Co. on May 31, 2024, March 15, 2024, and November 13, 2023, respectively. With an average price target of $13.33 between BTIG, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 237.55% upside for AC Immune SA from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/31/2024 | Buy Now | 102.53% | BTIG | Thomas Shrader | → $8 | Initiates | → Buy | Get Alert |
03/15/2024 | Buy Now | 305.06% | HC Wainwright & Co. | Andrew Fein | → $16 | Reiterates | Buy → Buy | Get Alert |
11/13/2023 | Buy Now | 305.06% | HC Wainwright & Co. | Andrew Fein | → $16 | Reiterates | Buy → Buy | Get Alert |
08/07/2023 | Buy Now | 305.06% | HC Wainwright & Co. | Andrew Fein | → $16 | Reiterates | Buy → Buy | Get Alert |
06/28/2023 | Buy Now | 305.06% | HC Wainwright & Co. | Andrew Fein | → $16 | Reiterates | Buy → Buy | Get Alert |
05/01/2023 | Buy Now | 305.06% | HC Wainwright & Co. | Andrew Fein | → $16 | Reiterates | → Buy | Get Alert |
04/19/2023 | Buy Now | 305.06% | HC Wainwright & Co. | Andrew Fein | → $16 | Reiterates | → Buy | Get Alert |
03/17/2023 | Buy Now | 305.06% | HC Wainwright & Co. | Andrew Fein | → $16 | Reiterates | → Buy | Get Alert |
07/11/2022 | Buy Now | 153.16% | SVB Leerink | Marc Goodman | $15 → $10 | Maintains | Outperform | Get Alert |
12/20/2021 | Buy Now | 279.75% | SVB Leerink | Marc Goodman | — | Maintains | Outperform | Get Alert |
The latest price target for AC Immune (NASDAQ:ACIU) was reported by BTIG on May 31, 2024. The analyst firm set a price target for $8.00 expecting ACIU to rise to within 12 months (a possible 102.53% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for AC Immune (NASDAQ:ACIU) was provided by BTIG, and AC Immune initiated their buy rating.
There is no last upgrade for AC Immune
There is no last downgrade for AC Immune.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AC Immune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AC Immune was filed on May 31, 2024 so you should expect the next rating to be made available sometime around May 31, 2025.
While ratings are subjective and will change, the latest AC Immune (ACIU) rating was a initiated with a price target of $0.00 to $8.00. The current price AC Immune (ACIU) is trading at is $3.95, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.